Process and Scaling

GE Speeds Up Production of Viral Vector-Based Therapeutics

April 17, 2018

The company is launching a new pre-fabricated, ready-to-run manufacturing facility that is expected to significantly decrease the production timeline for viral vector-based therapeutics.

Pharma 4.0

April 02, 2018

Pharma 4.0 envisions highly efficient automated processes, which could be continuous, batch, or a hybrid of these, driven by an integrated manufacturing control strategy.

Software Aids Product and Process Development for Pharmaceutical Tablets

March 09, 2018

The Natoli AIM Data Acquisition and Analytical Software for Natoli’s NP-RD10A single-station tablet press speeds research and development.

GlobalData Reports Need to Shift to Newer Vaccine Manufacturing Technologies

March 08, 2018

GlobalData reports the need to shift away from egg-based manufacturing of vaccines in light of influenza-related deaths.

Can Early Development Strategies Avoid Later-Stage Disasters?

March 02, 2018

Assessing potential formulation and manufacturing issues in early development phases can improve a drug’s chances for success.

Innopharma Bets on Manufacturing 4.0

March 01, 2018

Can an Irish analytics company and its CEO bring pharma closer to 21st-century practice?

Novo Nordisk Publishes New Study on Bioproduction of Chemicals

February 20, 2018

The study suggests that circumventing evolution in cell factories can enable the commercialization of new biobased chemicals to large-scale.

CPI and The Roslin Institute Collaborate on New Methods to Manufacture Biologics

February 01, 2018

A collaboration between The Centre for Process Innovation and The Roslin Institute aims to develop commercially viable and scalable methods of producing biologics using transgenic animals.

QbD and API Process Development: A Marriage of Chemistry and Engineering

February 01, 2018

Chemical engineers and chemists each bring unique skills to API process development and optimization. Success depends on their close collaboration, at both sponsor and CDMO facilities.

Univercells to Develop Antibody Production Platform with $2.9-Million Grant

January 23, 2018

The funding from the Walloon Region will enable Univercells to start developing a manufacturing platform aimed at driving down costs of biosimilars manufacturing.